aTyr Pharma, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 161
Rang # Quantité totale PI 8 137
Note d'activité PI 2,4/5.0    31
Rang # Activité PI 25 086
Symbole boursier
ISIN US0021202025
Capitalisation 131M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

89 1
28 1
41 1
0
 
Dernier brevet 2025 - Compositions and methods compris...
Premier brevet 2003 - Method for stimulating wound hea...
Dernière marque 2013 - ATYR PHARMA
Première marque 2007 - ATYR PHARMA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Compositions and methods comprising anti-nrp2 antibodies. Provided are antibodies and antigen-bi...
2023 Invention Compositions and methods comprising anti-nrp2 antibodies. Provided are affinity matured and huma...
Invention Compositions and methods comprising anti-nrp2 antibodies. Provided are antibodies, and antigen-b...
Invention Compositions and methods comprising anti-nrp2 antibodies. Provided are antibodies, and antigen-bi...
Invention Compositions and methods comprising anti-nrp2b antibodies. Provided are antibodies and antigen-b...
Invention Compositions and methods comprising anti-nrp2b antibodies. Provided are antibodies and antigen-bi...
2022 Invention Compositions and methods comprising anti-nrp2a antibodies. Provided are antibodies and antigen-b...
Invention Compositions and methods comprising anti-nrp2a antibodies. Provided are antibodies and antigen-bi...
Invention Compositions and methods comprising anti-nrp2 antibodies. Provided are antibodies and antigen-bin...
Invention Compositions and methods for treating nrp2-associated diseases. Provided are therapies, includin...
2021 Invention Histidyl-trna synthetase-fc conjugates. The present invention provides histidyl-tRNA synthetase ...
2020 Invention Therapeutic compositions comprising anti-nrp2 antibodies. Provided are affinity matured and human...
Invention Compositions and methods comprising anti-nrp2 antibodies. Provided are affinity matured and human...
Invention Histidyl-trna synthetase-fc conjugates. The present invention provides histidyl-tRNA synthetase a...
Invention Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical...
2019 Invention Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fra...
Invention Compositions and methods for treating nrp2-associated diseases. Provided are therapies, including...
2018 Invention Compositions and methods for treating lung inflammation. Provided are therapies, including combin...
Invention Compositions and methods for treating lung inflammation. Provided are therapies, including ...
2017 Invention Anti-hrs antibodies and combinaton therapies for treating cancers. Provided are antibodies that ...
Invention Anti-hrs antibodies and combination therapies for treating cancers. Provided are antibodies that ...
Invention Compositions and methods comprising glycyl-trna synthetases having non-canonical biological activ...
2013 P/S Pharmaceutical preparations for the treatment of vascular disorders, inflammatory disorders, name...
2007 P/S Pharmaceutical preparations.
P/S pharmaceutical research and development